Randomized prospective study showing the non-inferiority of tenofovir to entecavir in treatment-naïve chronic hepatitis B patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Randomized prospective study showing the non-inferiority of tenofovir to entecavir in treatment-naïve chronic hepatitis B patients

Published:2017-05-24 Issue:1 Volume:48 Page:59-68
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatol Res

Author:

Koike Kazuhiko¹,Suyama Kazuaki²,Ito Hiroshi²,Itoh Hiroshi³,Sugiura Wataru⁴

Affiliation:

1. Department of Gastroenterology, Graduate School of Medicine; University of Tokyo; Tokyo Japan

2. Medicines Development; GlaxoSmithKline K.K.; Tokyo Japan

3. Biomedical Data Sciences; GlaxoSmithKline K.K.; Tokyo Japan

4. Medical Affairs; GlaxoSmithKline K.K.; Tokyo Japan

Funder

GlaxoSmithKline K.K.

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hepr.12902/fullpdf

Reference26 articles.

1. Hepatocellular carcinoma epidemiology;Bosetti;Best Pract Res Clin Gastroenterol,2014

2. Efficacy of lamivudine on replication of hepatitis B virus in HIV-infected patients;Benhamou;Lancet,1995

3. Inhibitory effects of acyclic nucleoside phosphonates on human hepatitis B virus and duck hepatitis B virus infections in tissue culture;Heijtink;Antimicrob Agents Chemother,1994

4. A dose-finding study of once-daily oral telbivudine in HBeAg-positive patients with chronic hepatitis B virus infection;Lai;Hepatology,2004

5. Safety and efficacy of oral entecavir given for 28 days in patients with chronic hepatitis B virus infection;Man;Hepatology,2001

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy comparison of high-genetic barrier nucleos(t)ide analogues in treatment-naïve chronic hepatitis B patients: a network meta-analysis;The Korean Journal of Internal Medicine;2024-07-01

2. Kinetics of the hepatitis B core‐related antigen and treatment responses in chronic hepatitis B patients treated with tenofovir alafenamide;Hepatology Research;2024-04-29

3. A 28-year-old male patient with asymptomatic and multi-drug-resistant HBV infection: a case report;Egyptian Liver Journal;2024-02-26

4. Comparative effectiveness of tenofovir versus entecavir in patients with hepatitis B virus-related cirrhosis in Taiwan: a retrospective cohort study;Frontiers in Pharmacology;2023-12-19

5. Tenofovir versus entecavir on the prognosis of hepatitis B-related hepatocellular carcinoma after surgical resection: a randomised controlled trial;International Journal of Surgery;2023-06-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3